Rhoen Klinikum AG (ETR:RHK) has been given a €24.00 ($26.97) price target by investment analysts at Baader Bank in a note issued to investors on Thursday, June 8th. The firm presently has a “neutral” rating on the stock.

Separately, DZ Bank AG reaffirmed a “sell” rating on shares of Rhoen Klinikum AG in a report on Monday, May 29th.

Rhoen Klinikum AG (ETR:RHK) opened at 26.23 on Thursday. The stock has a market cap of €1.76 billion and a PE ratio of 122.57. Rhoen Klinikum AG has a 12-month low of €22.91 and a 12-month high of €27.51. The firm has a 50-day moving average price of €26.48 and a 200-day moving average price of €25.66.

ILLEGAL ACTIVITY WARNING: This piece of content was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this piece of content on another site, it was illegally stolen and republished in violation of US and international copyright & trademark legislation. The legal version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/06/19/rhoen-klinikum-ag-rhk-given-a-24-00-price-target-by-baader-bank-analysts-updated.html.

About Rhoen Klinikum AG

Receive News & Stock Ratings for Rhoen Klinikum AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rhoen Klinikum AG and related stocks with our FREE daily email newsletter.